Gynecologic Oncology-Indiana is categorized under Oncologists in Indianapolis, IN and active since 2007.
Gynecologic Oncology-Indiana was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact April Vande Voort, Office Manager at the company’s single location by writing to 8111 South Emerson Avenue, Indianapolis, Indiana IN 46237 or by phoning (317) 851-2555. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Gynecologic Oncology-Indiana |
| Contact Person: | April Vande Voort, Office Manager |
| Address: | 8111 South Emerson Avenue, Indianapolis, Indiana 46237 |
| Phone Number: | (317) 851-2555 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Gynecologic Oncology-Indiana was started in 2007 to provide professional Oncologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact April Vande Voort, Office Manager for inquiries that concern Gynecologic Oncology-Indiana by calling the company number (317) 851-2555, as your correspondence is most welcome. Additionally, the physical location of the single location of Gynecologic Oncology-Indiana can be found at the coordinates 39.650131,-86.082579 as well as the street address 8111 South Emerson Avenue in Indianapolis, Indiana 46237.
For its online presence, you may visit Gynecologic Oncology-Indiana’s website at and engage with its social media outlets through on Twitter and on Facebook.